HOME >> MEDICINE >> NEWS
GroPep completes final milestone of the path malaria vaccine initiative

Adelaide biotechnology company GroPep has completed the manufacture of two vaccine antigens as part of the project funded by the international PATH Malaria Vaccine Initiative (MVI).

GroPep will supply these vaccine antigens to the MVI for formulation and subsequent use in human clinical trials - expected to start in 2007.

Listed biopharmaceutical company GroPep Limited (ASX :GRO) announced today that it had successfully completed the second and final milestone of its agreement with the PATH Malaria Vaccine Initiative to manufacture malaria vaccine candidates for testing in human clinical trials.

GroPep reported the successful completion to Milestone 1 of the vaccine project in September 2003, developing scalable manufacturing processes for two malaria vaccine candidates.

Milestone 2 required scale-up of production and manufacturing to appropriate quality standards to enable the potential malaria vaccines to be tested in human safety trials. A sufficient quantity of each vaccine antigen has been manufactured.

PATH is an international, non-profit organisation that creates sustainable, culturally relevant solutions allowing global communities to break long-standing cycles of poor health. The Malaria Vaccine Initiative's (MVI) mission is to accelerate the development of malarial vaccines for the developing world. Malaria kills 7000 people each week and there is no vaccine.

MVI Director, Dr Melinda Moree congratulated GroPep on completing this important project milestone. "GroPep has made an important contribution to the quest to develop a vaccine against malaria."

GroPep's CEO, Bob Finder said that the manufacturing project had provided GroPep with a number of technical challenges that had been successfully met.

"As a Company, we are pleased to have successfully completed our part of the project, which may ultimately reduce the impact of this disease on millions of people worldwide," he said.
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
19-Dec-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
7. Acrux completes enrollment in key phase 2 trial
8. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
9. Im a Kid Too project completes first phase
10. 6 finalists compete for achievement in operations research
11. Heart Rhythm Society publishes final recommendations for heart patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2019)... ... February 18, 2019 , ... ... Seal of Approval® for Health Care Staffing Services Certification. The certification demonstrates Highland ... , “Highland Medical Group is pleased to receive certification from The Joint Commission, ...
(Date:2/14/2019)... LAND, Texas (PRWEB) , ... February 14, 2019 ... ... Las Vegas, QT Medical announced the launch of its Personal Cardiac Assistant (PCA ... Several health trackers including Apple Watch 4 can record single lead ECGs and ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... school locker rooms. Unfortunately, bullies also frequent hospital units, ambulatory care centers, clinics, ... , In this fully updated, second edition of What to Do When Nurses ...
(Date:2/13/2019)... ... 13, 2019 , ... Diameter Health , the leader in clinical data ... Security Management Act (FISMA) High General Support System Authority to Operate (ATO) for Diameter ... mandatory for the VA because of their work with confidential patient data. Protecting this ...
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Jig Patel and the dental ... an exceptionally talented and knowledgeable dentist from St. Louis, MO, to the ... such as CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, Dr. Merchant ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... 2019 , ... Researchers from the Icahn School of Medicine at Mount Sinai ... of the National Institutes of Health (NIH), for a five-year program called the U19 ... are to establish follicle-stimulating hormone (FSH), an important part of the reproductive system whose ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... Vision Source ® as the recipients for the ‘Empower Your Care Teams ... which were announced at the 2019 HIMSS Annual Conference and Exhibition ...
(Date:2/13/2019)... ... 13, 2019 , ... Sensible Surrogacy today has launched a ... childless couples who are unable to afford the staggering cost of surrogacy in ... North America or Eastern Europe for legal and secure surrogacy procedures. However North ...
Breaking Medicine Technology:
Cached News: